At the ZBED3 locus, for example, CRISPR-mediated activation or repression of an islet enhancer carrying a regulatory T2D risk variant [22, 25••] in EndoC βH3 cells resulted in changes in the expression of multiple genes [13••]. This evidence concerns the gene ZBED3 and type 2 diabetes mellitus.